Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
Theiss HD, Vallaster M, Rischpler C, Krieg L, Zaruba MM, Brunner S, Vanchev Y, Fischer R, Gröbner M, Huber B, Wollenweber T, Assmann G, Mueller-Hoecker J, Hacker M, Franz WM.
Theiss HD, et al.
Stem Cell Res. 2011 Nov;7(3):244-55. doi: 10.1016/j.scr.2011.05.003. Epub 2011 May 16.
Stem Cell Res. 2011.
PMID: 21752744
Free article.